KROS · Keros Therapeutics, Inc.

Summary

Keros Therapeutics, Inc. filed an 8-K on February 18, 2026, under Item 7.01 announcing a press release regarding Jasbir Seehra, the Company’s Pre. Item 9.01 discloses Exhibit 99.1 as the press release dated February 18, 2026.

Key takeaways

• Press release issued on February 18, 2026
• Item 7.01 Regulation FD Disclosure
• Jasbir Seehra identified as the Company’s Pre
• Exhibit 99.1: Press Release dated February 18, 2026
• Exhibit 104: Cover Page Interactive Data File